Searched for
EMCURE PHARMACEUTICALS ACQUISITION
Stocks in news: Paytm, Bajaj Auto, L&T, Bharti Airtel, Hero MotoCorpMarkets closed lower amid global headwinds and geopolitical worries. Several companies like Paytm, Bajaj Auto, and L&T are in focus due to ...- Emcure eyes India growth, global deals amid strong demandEmcure Pharmaceuticals is boosting domestic expansion, R&D, and manufacturing. The company is also exploring acquisition opportunities in I...
- Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...
- Delhivery chairman Deepak Kapoor, independent director Saugata Gupta resign from boardDelhivery chairman and independent director Deepak Kapoor has stepped down from the board with effect from April 1 as part of a planned res...
- Emcure Pharma Q2 profit rises 25%, revenue up 13% on broad-based growthPune-based Emcure Pharmaceuticals reported a 13.4% year-on-year rise in consolidated revenue to ₹2,270 crore in the September quarter, supp...
- Trump's 100% tariff on pharma will not impact generic makers, says Indian Pharma AllianceDonald Trump's proposed 100% tariffs on patented drugs from October 2025 are unlikely to immediately impact Indian pharma exports, which pr...
- India's pharma & healthcare sector records transactions worth $1.3 bn in Q2India's pharma and healthcare sector saw 57 deals worth $1.30 billion in the quarter ending June. This reflects a drop compared to the prev...
- Emcure Pharma to acquire remaining 20.42% stake in Zuventus Healthcare for Rs 724.9 crEmcure Pharmaceuticals will acquire the remaining 20.42% stake in Zuventus Healthcare Ltd from minority shareholders for ₹724.9 crore, a mo...
- Mankind Pharma eyes ₹9,000 cr via debt to stitch BSV dealThe average blended cost of the debt is likely to be around 8.50% with the firm seeking to borrow money over one- to-five years, said three...
- Mankind to use debt, internal accruals to fund BSV buyoutMankind Pharma announced a ₹13,630 crore acquisition of Bharat Serums and Vaccines (BSV) to be funded through internal accruals and a mix o...
- Mankind trumps EQT-ADIA to buy BSV for $1.67 bnThis is the largest acquisition by Mankind Pharma, India’s 4th largest pharma company by market share. A formal announcement regarding the ...
- IPO Analysis: Emcure has better-listed pharma alternativesEmcure Pharma, with its strong presence in gynaecology and HIV therapeutic areas, secured significant investments from anchor investors lik...
- Pharma raw material makers in race to tank up on CXO talentSome of these PE-owned platform companies include Advent International-led Cohance Lifesciences / Suven Pharma, PAG and CX Partners-funded ...
- Aim to take Emcure among top 5 pharma cos: MDOn being asked about the status of the vaccine, company's subsidiary Gennova is developing for COVID-19, Mehta said, "We are developing the...
- Meet India’s next generation of women leaders in pharmaThey are not afraid of taking business risks or foraying into newer businesses and have created environment and pushed for HR reforms targe...
- FIPB clears 10 FDI proposals worth Rs 607 croreBesides Alstom Manufacturing, Cipla proposal of Rs 145.22 crore has been approved by the FIPB chaired by Economic Affairs Secretary Shaktik...
- Emcure Pharmaceuticals acquires Canadian company and its marketing arm MarcanMarcan Pharma has over 60 approved products that are mainly available via McKesson and Kohl & Frisch, among other wholesalers, it claimed.
- Cipla, Mylan in race to buy select brands of Sun Pharma put up for saleThe total value of the seven drugs is estimated to be close to Rs 137 crore according to data available with AIOCDA.
- India's overseas investment in May down 39% year on yearOverseas direct investment by Indian companies stood at $ 1.59 billion in May 2014, down 39.3 per cent from a year ago.
- Pharma MNCs GSK, Merck, Pfizer and others prefer tie-ups over acquisitions with Indian firmsWith Indian drug makers flooding the developed markets, GSK, Merck, Pfizer now prefer tie-ups over acquisitions with Indian players.
Load More
